BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 3841067)

  • 1. Development of Organ-Preserving Radiation Therapy in Gastric Marginal Zone Lymphoma.
    Rolf D; Reinartz G; Rehn S; Kittel C; Eich HT
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic characteristics and therapeutic outcomes of primary gastrointestinal non-Hodgkin's lymphomas in central Anatolia, in Turkey.
    Eser B; Kaplan B; Unal A; Canoz O; Altuntas F; Sari HI; Er O; Ozkan M; Kucuk C; Arar M; Gursoy S; Cetin M
    Yonsei Med J; 2006 Feb; 47(1):22-33. PubMed ID: 16502482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up after curative surgery for early gastric lymphoma.
    Bartlett DL; Karpeh MS; Filippa DA; Brennan MF
    Ann Surg; 1996 Jan; 223(1):53-62. PubMed ID: 8554419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemorrhage and perforation of gastrointestinal neoplasms during chemotherapy.
    Randall J; Obeid ML; Blackledge GR
    Ann R Coll Surg Engl; 1986 Sep; 68(5):286-9. PubMed ID: 3491572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of two types of adjuvant chemotherapy in radiotherapy-treated patients with clinical stages I and II high-grade non-Hodgkin's lymphoma.
    Wagstaff J; Todd I; Deakin D; Wilkinson P; Scarffe JH; Harris M; Jones M; Crowther D
    Cancer Chemother Pharmacol; 1987; 20(1):53-8. PubMed ID: 3304688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined surgery and chemotherapy for the treatment of primary gastrointestinal intermediate- or high-grade non-Hodgkin's lymphomas.
    Bellesi G; Alterini R; Messori A; Bosi A; Bernardi F; di Lollo S; Ferrini PR
    Br J Cancer; 1989 Aug; 60(2):244-8. PubMed ID: 2765374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abdominal lymphoma--the place for surgery.
    Baildam AD; Williams GT; Schofield PF
    J R Soc Med; 1989 Nov; 82(11):657-60. PubMed ID: 2489024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy for early-stage gastrointestinal lymphoma.
    Liang R; Chiu E; Todd D; Chan TK; Choy D; Loke SL
    Cancer Chemother Pharmacol; 1991; 27(5):385-8. PubMed ID: 1998998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
    Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
    J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of the treatment of high-grade histology non-Hodgkin's lymphoma involving the gastrointestinal tract.
    Steward WP; Harris M; Wagstaff J; Scarffe JH; Deakin DP; Todd ID; Crowther D
    Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1195-200. PubMed ID: 3841067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined modality therapy of advanced non-Hodgkin's lymphoma: an analysis of remission duration and survival in 95 patients.
    Sullivan KM; Neiman PE; Kadin ME; Dahlberg S; Farewell VT; Rudolph RH; Bagley CM; Appelbaum FR; Thomas ED
    Blood; 1983 Jul; 62(1):51-61. PubMed ID: 6344932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of adjuvant radiotherapy and chemoradiotherapy following surgery in stage IE and IIE primary gastrointestinal tract non-Hodgkin's lymphoma.
    Chung HC; Roh JK; Koh EH; Kim JH; Hahn JS; Park IS; Min JS; Lee KS; Suh CO; Loh JJ
    Yonsei Med J; 1990 Jun; 31(2):144-55. PubMed ID: 2219972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.